openPR Logo
Press release

Hypertrophic Scars Therapeutics Pipeline: Drug Profile, Top Industry Intelligence and Therapeutic Development

01-15-2018 07:32 PM CET | Health & Medicine

Press release from: P&S Market Research

Hypertrophic Scars Therapeutics Pipeline: Drug Profile, Top

Hypertrophic scars currently exhibits a growing pipeline with nine drug candidates, P&S Market Research.

Body cells known as myofibroblasts produce excessive collagen during healing process which can be deposited as a bump and later changes to a hypertrophic scar. The study analyzed that the hypertrophic scars therapeutics pipeline comprises approximately nine drug candidates in different stages of development.

Access Detailed Report Summary at: https://www.psmarketresearch.com/market-analysis/hypertrophic-scars-therapeutics-pipeline-analysis

Majority of the pipeline drug candidates are being developed to be administered by the topical route. SCX-001 cream has demonstrated anti-scarring effects in two in-vivo Pre-clinical dermal models. SCX-001 cream’s safety as a topical agent has also been confirmed in non-clinical Investigational New Drug (IND) in-vitro and in-vivo studies.

Download Report Sample at: https://www.psmarketresearch.com/market-analysis/hypertrophic-scars-therapeutics-pipeline-analysis/report-sample

The drug development process involves specific targets such as connective tissue growth factor inhibition which is the probable mechanism of action for the treatment of hypertrophic scars. Thus, this specific targeted therapy provides opportunities to the companies for better and targeted drug development.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=hypertrophic-scars-therapeutics-pipeline-analysis

Technological advancements have been strengthening the development of pipeline drugs for the treatment of hypertrophic scars. For instance, The RNA interference (RNAi) technology, was used in the development of OLX101 by OliX Pharmaceuticals, Inc.

Some of the players developing drugs for the treatment of hypertrophic scars include RXi Pharmaceuticals Corporation, Sirnaomics, Inc., ScarX Therapeutics, Inc., and Scarless Laboratories, Inc.

Hypertrophic Scars Therapeutics Pipeline Analysis

• By Phase
• By Molecule Type
• By Route of Administration
• By Company

About P&S Market Research
P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries.
With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.

Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hypertrophic Scars Therapeutics Pipeline: Drug Profile, Top Industry Intelligence and Therapeutic Development here

News-ID: 900714 • Views:

More Releases from P&S Market Research

Smart Cities Market Size, Revenue, Technology, Competitive Analysis, Growth Drivers and Opportunities by 2023
Smart Cities Market Size, Revenue, Technology, Competitive Analysis, Growth Driv …
The global smart cities market is growing at a CAGR above 20% during 2018 - 2023 and will reach $2578.0 billion by 2023. Due to significant growth in automation technologies such as internet of things (IoT) and adoption of cloud based technologies, the global smart cities market is gaining huge traction. In addition, effective city asset management for public welfare, substantial operational cost savings, and automated public data generation applications
Global Sports Food Market Expected to Witness 9.2% CAGR During 2016 – 2022
Global Sports Food Market Expected to Witness 9.2% CAGR During 2016 – 2022
The global sports food market is expected to grow at a CAGR of 9.2% in terms of value during 2016 - 2022. Among the various types, the energy bars segment accounted for the largest share (71.5%) in the global sports food market in 2015. Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/sports-food-market/report-sample The manufacturers are trying to bring about products with the best blend of taste and healthy ingredients. They have started to
Sports Nutrition Market by Type, Distribution Channel, Region, Growth and Demand Forecast to 2022
Sports Nutrition Market by Type, Distribution Channel, Region, Growth and Demand …
The global sports nutrition market is expected to grow at a CAGR of 8.4% in terms of value during 2016 - 2022. Among the various types, the sports drinks segment accounted for largest share (61.4%) in the global sports nutrition market in 2015. Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/sports-nutrition-market/report-sample The increasing health concerns, such as obesity and awareness of physical appearances among all consumers groups is driving the demand for sports
Orthopedic Trauma Devices Market Supply Chain Trends Mapping the Latest Technological Advancements
Orthopedic Trauma Devices Market Supply Chain Trends Mapping the Latest Technolo …
The global orthopedic trauma devices market is growing due to the increasing frequency of fractures, along with the growth of aging population. The advantageous features posed by orthopedic trauma devices, such as internal and external fixators to set a fracture, and in repositioning of bone fragments into their normal alignment are also driving the growth of the market worldwide. Furthermore, the internal fixators have reduced the hospital stays, reduced the

All 5 Releases


More Releases for Hypertrophic

Hypertrophic Scar Treatment market
The global Hypertrophic Scar Treatment market report published by Reports and Data assesses the Hypertrophic Scar Treatment market with regards to market size, market share, revenue growth, key segments, and regional bifurcation. The global Hypertrophic Scar Treatment market is highly fragmented with numerous players operating on a global and regional level. The companies are engaged in mergers and acquisitions, joint ventures, and collaborations along with product advancements and R&D activities
Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Opportunity Analysis, 2018 …
Hypertrophic Cardiomyopathy (HCM) is a genetic condition of heart muscle associated with the thickened heart muscle wall. HCM is caused due to the changes or mutation in one or more genes, which is inherited. Hypertrophic cardiomyopathy affects the muscular wall of heart making them stiff. This thickening makes harder for the heart to pump blood out of the heart and around the body. Shortness of breath, palpitations, chest pain, and
Hypertrophic Cardiomyopathy - Pipeline Review and Industry Forecast 2017-2022
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Hypertrophic Cardiomyopathy - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Hypertrophic Cardiomyopathy (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Request
Hypertrophic Cardiomyopathy Therapeutics Market Demand and Growth by 2023
Global Hypertrophic Cardiomyopathy Therapeutics Market – Key Trends With heart diseases emerging as one of the most common causes of mortality among men and women worldwide, Transparency Market Research (TMR) expects the demand for hypertrophic cardiomyopathy (HCM) therapeutics to surge considerably. Furthermore, the market is expected to gain significant impetus from successful government interventions aimed at spreading awareness about hypertrophic cardiomyopathy. Browse the Complete Report Details for this Market at: http://www.transparencymarketresearch.com/hypertrophic-cardiomyopathy-therapeutics-market.html TMR
Global Hypertrophic Cardiomyopathy Therapeutics Market: Key vendors - Merck, Pfi …
Latest industry research report on: Global Hypertrophic Cardiomyopathy Therapeutics Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts HCM is the enlargement of the heart muscle (myocardium), which disrupts the functions of the heart. HCM is mostly caused due to gene mutation and is a significant cause of sudden cardiac death in any age group. Hypertrophy is defined as an enlargement of a tissue or organ,
Hypertrophic Cardiomyopathy Therapeutics Market to Gain Significant Impetus from …
The global hypertrophic cardiomyopathy (HCM) therapeutics market is dominated by companies exhibiting high sales. However, generic manufacturers are making their presence felt in the market gradually. As per Transparency Market Research (TMR), the top three companies in the market, Sanofi S.A., Pfizer, Inc., and Merck & Co., accounted for a share of over 64.5%, which points toward a highly consolidated vendor landscape. Browse the Complete Details of this Report at: